基于pcDNA3.1框架的p38β真核表达质粒的构建及其功能研究
Study on Construction and Functional Characterization of a pcDNA3.1-Based Eukaryotic Expression Plasmid for p38β
摘要: 目的:为探究p38β在巨噬细胞炎症反应中的调控机制,建立鼠源pcDNA3.1-N-3 × Flag-p38β真核表达质粒,转染RAW264.7细胞建立实验模型。通过脂多糖(LPS)刺激,从细胞增殖、凋亡、促炎因子表达三个方面研究该重组质粒的生物学功能。方法:通过PCR扩增p38β基因,构建基于pcDNA3.1框架的p38β真核表达质粒。利用EcoRI/XhoI限制性位点双酶切,将纯化的目的片段进行体外重组,转化细菌感受态细胞。经酶切鉴定、测序与比对分析后,将重组质粒转染至LPS刺激的RAW264.7细胞中,通过Western blot和qRT-PCR技术及EdU法、ELISA法检测其对LPS诱导的RAW264.7细胞增殖和凋亡的影响,以及肿瘤坏死因子-α (TNF-α)、白细胞介素-6 (IL-6)、白细胞介素-1β (IL-1β)等炎症介质的分泌水平。其中,Western blot技术用于检测凋亡相关蛋白表达,qRT-PCR解析基因转录调控,EdU法检测DNA合成活性,ELISA法检测炎症因子分泌量。结果:双酶切鉴定和Western blot结果显示pcDNA3.1-N-3 × Flag-p38β真核表达质粒构建成功并表达。EdU实验显示:LPS刺激RAW264.7细胞24 h后,p38β过表达组的细胞存活率显著低于空载体对照组。Western blot及PCR结果显示:p38β过表达组细胞的促凋亡蛋白Bax表达高于转染空载体的对照组,抗凋亡蛋白Bcl-2及增殖蛋白PCNA表达低于空载体对照组(均P < 0.05)。Western blot和ELISA结果显示:pcDNA3.1-N-3 × Flag-p38β质粒转染使RAW264.7细胞中TNF-α、IL-6、IL-1β的表达较对照组升高,差异均有统计学意义(P < 0.05)。结论:p38β能抑制LPS刺激的RAW264.7细胞增殖,并促进其凋亡,同时能上调TNF-α、IL-6和IL-1β等炎症介质的表达。
Abstract: Objective: To investigate the regulatory mechanism of p38β in macrophage inflammatory responses, a murine pcDNA3.1-N-3 × Flag-p38β eukaryotic expression plasmid was constructed and transfected into RAW264.7 cells to establish an experimental model. Lipopolysaccharide (LPS) stimulation was used to study the biological functions of this recombinant plasmid in terms of cell proliferation, apoptosis, and pro-inflammatory cytokine expression. Methods: The p38β gene was amplified by PCR to construct the p38β eukaryotic expression plasmid based on the pcDNA3.1 framework. Purified target fragments were recombined in vitro using EcoRI/XhoI restriction sites and transformed into bacterial competent cells. After restriction enzyme digestion, sequencing, and comparative analysis, the recombinant plasmid was transfected into LPS-stimulated RAW264.7 cells. Western blot, qRT-PCR, EdU assay, and ELISA were employed to assess its effects on LPS-induced proliferation, apoptosis, and secretion levels of inflammatory mediators such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β). Specifically, Western blot analyzed apoptosis-related protein expression, qRT-PCR elucidated transcriptional regulation, the EdU assay measured DNA synthesis activity, and ELISA quantified inflammatory cytokine secretion. Results: Restriction enzyme digestion and Western blot confirmed the successful construction and expression of the pcDNA3.1-N-3 × Flag-p38β plasmid. The EdU assay revealed that 24 h after LPS stimulation, cell viability in the p38β overexpression group was significantly lower than in the empty vector control group. Western blot and qRT-PCR results demonstrated that the p38β overexpression group exhibited higher expression of the pro-apoptotic protein Bax and lower expression of the anti-apoptotic protein Bcl-2 and proliferating cell nuclear antigen (PCNA) compared to the control group (P < 0.05). Additionally, Western blot and ELISA showed that transfection with pcDNA3.1-N-3 × Flag-p38β significantly upregulated the expression of TNF-α, IL-6, and IL-1β in RAW264.7 cells compared to the control group (P < 0.05). Conclusion: p38β inhibits LPS-induced proliferation and promotes apoptosis in RAW264.7 cells while upregulating the expression of inflammatory mediators such as TNF-α, IL-6, and IL-1β.
文章引用:饶先玥, 方婧, 吴体玲, 汪浩. 基于pcDNA3.1框架的p38β真核表达质粒的构建及其功能研究[J]. 临床医学进展, 2025, 15(5): 396-404. https://doi.org/10.12677/acm.2025.1551385

参考文献

[1] Jiang, Y., Chen, C., Li, Z., et al. (1996) Characterization of the Structure and Function of a New Mitogen-Activated Protein Kinase (p38β). Journal of Biological Chemistry, 271, 17920-17926. [Google Scholar] [CrossRef] [PubMed]
[2] Jiang, Y., Gram, H., Zhao, M., et al. (1997) Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-Activated Protein Kinases, p38δ. Journal of Biological Chemistry, 272, 30122-30128. [Google Scholar] [CrossRef] [PubMed]
[3] Lisnock, J., Tebben, A., Frantz, B., O’Neill, E.A., Croft, G., O’Keefe, S.J., et al. (1998) Molecular Basis for P38 Protein Kinase Inhibitor Specificity. Biochemistry, 37, 16573-16581. [Google Scholar] [CrossRef] [PubMed]
[4] Kim, E.K. and Choi, E. (2010) Pathological Roles of MAPK Signaling Pathways in Human Diseases. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1802, 396-405. [Google Scholar] [CrossRef] [PubMed]
[5] Stein, B., Yang, M.X., Young, D.B., Janknecht, R., Hunter, T., Murray, B.W., et al. (1997) P38-2, a Novel Mitogen-Activated Protein Kinase with Distinct Properties. Journal of Biological Chemistry, 272, 19509-19517. [Google Scholar] [CrossRef] [PubMed]
[6] Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444. [Google Scholar] [CrossRef] [PubMed]
[7] 张一凡, 刘萍. 丹酚酸B通过STAT3/NF-κB信号通路改善动脉粥样硬化小鼠及RAW264.7细胞炎症反应[J]. 中华中医药杂志, 2023, 38(1): 141-147.
[8] Zhang, T., Guo, J., Gu, J., Chen, K., Li, H. and Wang, J. (2019) Protective Role of mTOR in Liver Ischemia/Reperfusion Injury: Involvement of Inflammation and Autophagy. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 7861290. [Google Scholar] [CrossRef] [PubMed]
[9] Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., et al. (1994) A Protein Kinase Involved in the Regulation of Inflammatory Cytokine Biosynthesis. Nature, 372, 739-746. [Google Scholar] [CrossRef] [PubMed]
[10] Hansen, T.E. and Jørgensen, J.B. (2007) Cloning and Characterisation of P38 MAP Kinase from Atlantic Salmon. Molecular Immunology, 44, 3137-3146. [Google Scholar] [CrossRef] [PubMed]
[11] Zhu, T., Zhang, W., Feng, S. and Yu, H. (2016) Emodin Suppresses LPS-Induced Inflammation in RAW264.7 Cells through a PPARγ-Dependent Pathway. International Immunopharmacology, 34, 16-24. [Google Scholar] [CrossRef] [PubMed]
[12] Khavari, T.A. and Rinn, J.L. (2007) Ras/Erk MAPK Signaling in Epidermal Homeostasis and Neoplasia. Cell Cycle, 6, 2928-2931. [Google Scholar] [CrossRef] [PubMed]
[13] Garcia, J., Lemercier, B., Roman-Roman, S., et al. (1998) A Mycoplasma fermentans-Derived Synthetic Lipopeptide Induces AP-1 and NF-κB Activity and Cytokine Secretion in Macrophages via the Activation of Mitogen-Activated Protein Kinase Pathways. Journal of Biological Chemistry, 273, 34391-34398. [Google Scholar] [CrossRef] [PubMed]
[14] Byeon, S.E., Lee, J., Yoo, B.C., Sung, G.H., Kim, T.W., Park, H.J., et al. (2010) P38-Targeted Inhibition of Interleukin-12 Expression by Ethanol Extract from Cordyceps bassiana in Lipopolysaccharide-Activated Macrophages. Immunopharmacology and Immunotoxicology, 33, 90-96. [Google Scholar] [CrossRef] [PubMed]
[15] Cicenas, J., Zalyte, E., Rimkus, A., Dapkus, D., Noreika, R. and Urbonavicius, S. (2017) JNK, P38, ERK, and SGK1 Inhibitors in Cancer. Cancers, 10, Article 1. [Google Scholar] [CrossRef] [PubMed]
[16] Johnson, G.L. and Lapadat, R. (2002) Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and P38 Protein Kinases. Science, 298, 1911-1912. [Google Scholar] [CrossRef] [PubMed]
[17] Guo, H., Callaway, J.B. and Ting, J.P. (2015) Inflammasomes: Mechanism of Action, Role in Disease, and Therapeutics. Nature Medicine, 21, 677-687. [Google Scholar] [CrossRef] [PubMed]
[18] Roche, O., Fernández-Aroca, D.M., Arconada-Luque, E., García-Flores, N., Mellor, L.F., Ruiz-Hidalgo, M.J., et al. (2020) P38β and Cancer: The Beginning of the Road. International Journal of Molecular Sciences, 21, Article 7524. [Google Scholar] [CrossRef] [PubMed]